Adagene Cash Conversion Cycle 2011-2026 | ADAG

Annual Cash Conversion Cycle Adagene

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	53.8	125	182	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
182	53.8	120

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	-400	$ 0.79	-1.15 %	$ 4.31 M	China
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
AbCellera Biologics ABCL	173	$ 3.49	0.58 %	$ 1.04 B	Canada
Frequency Therapeutics FREQ	76.1	-	-	$ 528 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Grifols, S.A. GRFS	0.000171	$ 7.81	-2.01 %	$ 6.83 B	Spain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
BioCardia BCDA	101	$ 1.26	-0.79 %	$ 26.7 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Anika Therapeutics ANIK	270	$ 14.2	-0.7 %	$ 208 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 6.68	-4.57 %	$ 183 M	Israel
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
AVEO Pharmaceuticals AVEO	-123	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.54	-5.22 %	$ 16 M	USA
Certara CERT	81.8	$ 6.67	1.6 %	$ 1.07 B	USA